Slide 1SPIRIT IV A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease One Year Clinical…

Slide 1Upendra Kaul, MD for the TUXEDO INDIA Investigators Paclitaxel Eluting Versus Everolimus Eluting Stents in Patients with Diabetes Mellitus and Coronary Artery Disease…

Slide 1 3rd CEEGI Advisory Board1 Resolute in the DES era: Indications & Limitations Georgios I. Papaioannou, MD, MPH, FACC, FSCAI Athens Medical Center Cardiac Catheterization…

Slide 1 New Drug-Eluting Stents Soo-Joong Kim M.D., PhD. Department of Cardiology, Internal Medicine, Kyung Hee University Medical Center Slide 2 M/57 yr. Chest pain on exertion…

SPIRIT IV A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease One Year Clinical…

RESOLUTE US 2 Year Clinical Outcomes from the Pivotal RESOLUTE US Study Laura Mauri MD, MSc on behalf of the RESOLUTE US Investigators Brigham and Womenâs Hospital Boston,…

Nothing to disclose Presenter Disclosure Information: In head-to-head randomized trials, everolimus-eluting stent (EES; Xience) has proven superior to the pacliaxel-eluting…